On Feb. 26, 2015, South Carolina’s Supreme Court ordered Johnson & Johnson to pay $136 million is Risperdal lawsuit penalties.
Risperdal Gynecomastia Lawsuits Are Back on the Rise
Risperdal, an antipsychotic developed by the Janssen brand of Johnson & Johnson, has long been approved by the Food and Drug Administration for schizophrenia.